AU2002216125A1 - Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus - Google Patents

Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus

Info

Publication number
AU2002216125A1
AU2002216125A1 AU2002216125A AU1612502A AU2002216125A1 AU 2002216125 A1 AU2002216125 A1 AU 2002216125A1 AU 2002216125 A AU2002216125 A AU 2002216125A AU 1612502 A AU1612502 A AU 1612502A AU 2002216125 A1 AU2002216125 A1 AU 2002216125A1
Authority
AU
Australia
Prior art keywords
gene
development
diabetes mellitus
therapeutic approaches
glucokinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216125A
Inventor
Fatima Bosch Tubert
Ma Del Tura Ferre Masferrer
Alejandro Mas Monteys
Pedro Jose Otaegui Goya
Efren Riu Pastor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitat Autonoma de Barcelona UAB
Original Assignee
Universitat Autonoma de Barcelona UAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat Autonoma de Barcelona UAB filed Critical Universitat Autonoma de Barcelona UAB
Publication of AU2002216125A1 publication Critical patent/AU2002216125A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01002—Glucokinase (2.7.1.2)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0325—Animal model for autoimmune diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002216125A 2000-12-20 2001-12-19 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus Abandoned AU2002216125A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200003056 2000-12-20
ES200003056A ES2170720B1 (en) 2000-12-20 2000-12-20 JOINT USE OF THE INSULIN GENE AND THE GLUCOQUINASE GENE IN THE DEVELOPMENT OF THERAPEUTIC APPROXIMATIONS FOR MELLITUS DIABETES.
PCT/ES2001/000493 WO2002049423A1 (en) 2000-12-20 2001-12-19 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus

Publications (1)

Publication Number Publication Date
AU2002216125A1 true AU2002216125A1 (en) 2002-07-01

Family

ID=8496075

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216125A Abandoned AU2002216125A1 (en) 2000-12-20 2001-12-19 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus

Country Status (6)

Country Link
US (1) US20040055023A1 (en)
EP (1) EP1360898A1 (en)
AU (1) AU2002216125A1 (en)
CA (1) CA2432506A1 (en)
ES (1) ES2170720B1 (en)
WO (1) WO2002049423A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007063225A (en) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd Imidazopyridine compound
JP5302012B2 (en) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド Glucokinase activator
WO2007143434A2 (en) 2006-05-31 2007-12-13 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents
EP2091947A2 (en) 2006-12-20 2009-08-26 Takeda San Diego, Inc. Glucokinase activators
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators
AP3277A (en) * 2009-01-07 2015-05-31 Haidong Huang Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
WO2012007458A1 (en) 2010-07-12 2012-01-19 Universidad Autónoma De Barcelona Gene therapy composition for use in diabetes treatment
WO2013117776A1 (en) * 2012-02-08 2013-08-15 Fundación Pública Andaluza Progreso Y Salud Glucokinase enzymes with increased activity and use thereof in the treatment and/or prevention of diabetes mellitus
EP2692868A1 (en) 2012-08-02 2014-02-05 Universitat Autònoma De Barcelona Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
EP3194430A1 (en) 2014-09-16 2017-07-26 Universitat Autònoma De Barcelona Adeno-associated viral vectors for the gene therapy of metabolic diseases
EP3242945B1 (en) 2015-01-07 2021-09-01 Universitat Autònoma de Barcelona Single-vector gene construct comprising insulin and glucokinase genes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0707646A1 (en) * 1993-06-28 1996-04-24 The Board Of Regents, The University Of Texas System Vectors for genetically engineered cells that produce insulin in response to glucose
AU6258894A (en) * 1994-03-14 1995-10-03 Universitat Autonoma De Barcelona Chimeric gene using the gene or cdna of insuline, specially for the gene therapy of diabetes
ZA969435B (en) * 1995-11-16 1997-06-02 Antonomous University Of Barce Treatment of diabetes with a glucokinase gene
AU1557000A (en) * 1998-11-20 2000-06-13 Autonomous University of Barcelona, The Insulin production by engineered muscle cells

Also Published As

Publication number Publication date
ES2170720B1 (en) 2003-12-16
CA2432506A1 (en) 2002-06-27
US20040055023A1 (en) 2004-03-18
ES2170720A1 (en) 2002-08-01
EP1360898A1 (en) 2003-11-12
WO2002049423A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
AU1516301A (en) Use of a milk protein hydrolysate in the treatment of diabetes
AU2002353790A1 (en) Syringe and reconstitution syringe
AU2314600A (en) Sintered cemented carbide body and use thereof
AU4450700A (en) Insulin crystals for pulmonary administration
AU2001241423A1 (en) Needleless syringe
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
AU4072799A (en) 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
AU2440700A (en) Oral arginine and insulin secretion
AU2002213698A1 (en) Needleless syringe for the subcutaneous delivery of therapeutic agents
AU2003221173A1 (en) Placenta-origin mesenchymal cells and medicinal use thereof
AU2002216125A1 (en) Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus
AU5840200A (en) Treatment of diabetes and related pathologies
AU2002254942A1 (en) Paracetamol solutions which are stable in storage and ready for infusion
AU2289601A (en) The use of procyanidins in the modulation of cytokine gene expression and protein secretion
AU2003235307A1 (en) Crystal of glucokinase protein, and method for drug design using the crystal
AU2003252182A1 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
AU5453300A (en) Insulin crystals for pulmonary administration
AU2001288061A1 (en) Drug resistance-associated gene and use thereof
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AP9901717A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL134045A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
AU2001268474A1 (en) Use of amp kinase activators for treatment of type 2 diabetes and insulin resistance
HUP0203285A3 (en) Pharmaceutical composition comprising an insulin sensitizer and its use
AU2001270903A1 (en) Needleless syringe
AU1189101A (en) Therapeutic applications of flint polypeptides